UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
 
 
For the month of September 2025
 
Commission File Number 001-15170
 
 
GSK plc
(Translation of registrant's name into English)
 
 
79 New Oxford Street, London, WC1A 1DG
(Address of principal executive office)
 
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F . . . .X. . . . Form 40-F . . . . . . . .
 
 
GSK plc (the 'Company')
Transaction notification
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
Wendy Becker
 
b)
Position/status
Independent Non-Executive Director
 
c)
Initial notification/ amendment
Initial notification
 
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
Ordinary shares of 31 ¼ pence each ('Ordinary Shares')
 
ISIN: GB00BN7SWP63
 
b)
Nature of the transaction
Purchase of 526 Ordinary Shares
 
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
£15.0300
526
 
 
d)
Aggregated information
 
Aggregated volume
 
Price
 
N/A (single transaction)
e)
Date of the transaction
2025-09-19
 
f)
Place of the transaction
 
London Stock Exchange (XLON)
 
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
Elizabeth (Liz) McKee Anderson
 
b)
Position/status
Independent Non-Executive Director
 
c)
Initial notification/ amendment
Initial notification
 
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
 
ISIN: US37733W2044
 
b)
Nature of the transaction
Purchase of 240 ADSs
 
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
$40.7387
 
240
 
d)
Aggregated information
 
Aggregated volume
 
Price
 
N/A (single transaction)
e)
Date of the transaction
2025-09-19
 
f)
Place of the transaction
 
New York Stock Exchange (XNYS)
 
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
Charles Bancroft
 
b)
Position/status
Senior Independent Non-Executive Director
 
c)
Initial notification/ amendment
Initial notification
 
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
 
ISIN: US37733W2044
 
b)
Nature of the transaction
Purchase of 1,880 ADSs
 
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
$40.7387
1,880
 
 
d)
Aggregated information
 
Aggregated volume
 
Price
 
N/A (single transaction)
e)
Date of the transaction
2025-09-19
 
f)
Place of the transaction
 
New York Stock Exchange (XNYS)
 
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
Dr Hal Barron
 
b)
Position/status
Non-Executive Director
 
c)
Initial notification/ amendment
 
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
 
ISIN: US37733W2044
 
b)
Nature of the transaction
Purchase of 240 ADSs
 
c)
Price(s) and volume(s)
 
Price(s)
 
Volume(s)
 
$40.7387
240
 
 
d)
Aggregated information
 
Aggregated volume
 
Price
 
N/A (single transaction)
e)
Date of the transaction
2025-09-19
 
f)
Place of the transaction
 
New York Stock Exchange (XNYS)
 
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
Dr Anne Beal
 
b)
Position/status
Independent Non-Executive Director
 
c)
Initial notification/ amendment
 
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
  
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
 
ISIN: US37733W2044
 
b)
Nature of the transaction
Purchase of 240 ADSs
 
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
$40.7387
240
 
 
d)
Aggregated information
 
Aggregated volume
 
Price
 
N/A (single transaction)
e)
Date of the transaction
2025-09-19
 
f)
Place of the transaction
 
New York Stock Exchange (XNYS)
 
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
Dr Hal Dietz
 
b)
Position/status
Independent Non-Executive Director
 
c)
Initial notification/ amendment
 
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
 
ISIN: US37733W2044
 
b)
Nature of the transaction
Purchase of 240 ADSs
 
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
$40.7387
240
 
 
d)
Aggregated information
 
N/A (single transaction)
Aggregated volume
 
Price
 
 
e)
Date of the transaction
2025-09-19
 
f)
Place of the transaction
 
New York Stock Exchange (XNYS)
 
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
Dr Jeannie Lee
 
b)
Position/status
Independent Non-Executive Director
 
c)
Initial notification/ amendment
Initial notification
 
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
 
ISIN: US37733W2044
 
b)
Nature of the transaction
Purchase of 239 ADSs
 
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
$40.7387
239
 
 
d)
Aggregated information
 
Aggregated volume
 
Price
 
N/A (single transaction)
e)
Date of the transaction
2025-09-19
 
f)
Place of the transaction
 
New York Stock Exchange (XNYS)
 
 
1.
Details of PDMR/person closely associated with them ('PCA')
 
a)
Name
Dr Vishal Sikka
 
b)
Position/status
Independent Non-Executive Director
 
c)
Initial notification/ amendment
Initial notification
 
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
 
a)
Name
GSK plc
 
b)
LEI
5493000HZTVUYLO1D793
 
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
 
ISIN: US37733W2044
 
b)
Nature of the transaction
Purchase of 827 ADSs
 
c)
Price(s) and volume(s)
 
Price(s)
Volume(s)
 
 
$40.7387
827
 
 
d)
Aggregated information
 
Aggregated volume
 
Price
 
N/A (single transaction)
e)
Date of the transaction
2025-09-19
 
f)
Place of the transaction
 
New York Stock Exchange (XNYS)
 
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
 
GSK plc
 
(Registrant)
 
 
Date: September 22, 2025
 
 
 
 
By:/s/ VICTORIA WHYTE
--------------------------
 
 
 
Victoria Whyte
 
Authorised Signatory for and on
 
behalf of GSK plc